Fidia S.p.A. (BIT:FDA)
0.0194
-0.0016 (-7.62%)
Oct 13, 2026, 9:09 AM CET
Fidia Employees
Fidia had 146 employees as of December 31, 2025. The number of employees decreased by 13 or -8.18% compared to the previous year. That makes Fidia the 28,977th largest employer in the world and 242nd in Italy.
Employees
146
Change
-13
Growth
-8.18%
Revenue / Employee
€209,329
Profits / Employee
€7,116
Market Cap
9.69M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 146 | -13 | -8.18% |
| Jun 30, 2025 | 140 | - | - |
| Dec 31, 2024 | 159 | -34 | -17.62% |
| Dec 31, 2023 | 193 | -4 | -2.03% |
| Dec 31, 2022 | 197 | - | - |
| Jun 30, 2020 | 289 | -42 | -12.69% |
| Mar 31, 2020 | 299 | -32 | -9.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Danieli & C. Officine Meccaniche | 10,088 |
| Biesse | 3,601 |
| SIT S.p.A. | 1,916 |
| Tesmec | 937 |
| ILPRA | 429 |
| OSAI Automation System | 222 |
| Marzocchi Pompe | 220 |
| Valtecne | 181 |
Fidia News
- 13 hours ago - Diazyme Laboratories, Inc. Acquires Alfa Wassermann Diagnostic Technologies LLC. - Financial Post
- 18 hours ago - Dr. Scott Gottlieb on push to fast-track cancer vaccines, flu season and AI integration in hospitals - CNBC
- 22 hours ago - Ex-US FDA official to lead Hong Kong’s new medical products regulator - South China Morning Post
- 1 day ago - FDA Grants Fast Track Tag To Leads Biolabs' Opamtistomig In Biliary Tract Cancer - Nasdaq
- 1 day ago - Roche's Vamikibart Shows One-Year Vision Benefits In Uveitic Macular Edema; FDA Accepts Filing - Nasdaq
- 1 day ago - Grail Stock Hit a 12-Month High After Its FDA Panel Win. But Here's the Risk Investors Shouldn't Ignore. - The Motley Fool
- 2 days ago - FDA may allow some toxic chemicals to be added to food without safety review. Experts are alarmed - The Guardian
- 3 days ago - Asahi Kasei Wins FDA Approval For HOVILPRI To Treat Drug-Resistant HSV In Immunocompromised Adults - Nasdaq